AbCellera is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology.
Looking for a particular AbCellera employee's phone or email?
The AbCellera annual revenue was $33.1 million in 2026.
Carl Hansen is the CEO of AbCellera.
496 people are employed at AbCellera.
AbCellera is based in Vancouver, British Columbia.
The NAICS codes for AbCellera are [5417, 54, 541714, 541, 54171].
The SIC codes for AbCellera are [873, 8731, 87].